SURG — Surgepays Cashflow Statement
0.000.00%
- $59.59m
- $21.98m
- $137.14m
Annual cashflow statement for Surgepays, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -8.45 | -10.7 | -13.5 | -0.553 | 20.6 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 1.85 | 1.28 | 0.093 | 0.234 | 2.46 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.159 | 3.94 | -2.61 | 0.179 | -11 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -6.53 | -4.33 | -15.3 | 0.793 | 10.3 |
Capital Expenditures | -0.228 | -0.007 | -0.051 | -0.311 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.195 | 0.015 | -0.325 | -1.19 | -0.281 |
Acquisition of Business | |||||
Sale of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.032 | 0.008 | -0.377 | -1.5 | -0.281 |
Financing Cash Flow Items | — | -0.162 | -2.22 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 6.47 | 4.65 | 21.3 | 1.46 | -2.42 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.099 | 0.328 | 5.61 | 0.752 | 7.59 |